VolitionRx prices $4.6M primary offering at $1.55/share with warrants; net proceeds $4.1M

Filed June 9, 2026 · ~2 min read

Key Changes

• high

  VolitionRx is offering 2,960,000 shares at $1.55 per share, each paired with a warrant to buy one-half share; pre-funded warrants are also offered.

  The Offering verify on EDGAR →
• high

  The company estimates net proceeds of approximately $4.1 million after placement agent fees and expenses, assuming full exercise of pre-funded warrants and no warrant exercises.

  Use of Proceeds verify on EDGAR →
• medium

  Net proceeds are earmarked for research and product development, clinical studies, commercialization, working capital, and repayment of Lind Notes.

  Use of Proceeds verify on EDGAR →